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Abstract
Background: Therapeutic hypothermia and targeted temperature management are considered stand-
ard of care in the management of patients following out-of-hospital cardiac arrests due to shockable 
rhythms to improve neurological outcomes. In those presenting out-of-hospital cardiac arrests associ-
ated with non-shockable rhythms, the benefit of hypothermia is less clear. In this review we try to clarify 
the utility of implementing a hypothermia protocol after cardiac arrests due to non-shockable rhythms. 
Methods: PUBMED, Ovid, MEDLINE, EMBASE, and clinicaltrials.gov websites were searched 
through during October, 2016 using the terms “non shockable”, “hypothermia,” and “cardiac arrest.” 
Studies were excluded if they solely evaluated in-hospital cardiac arrests, shockable rhythms, and/or 
pediatric patients. Data was extracted by two authors.
Results: Forty studies were included in this review, most of which were not randomized or controlled, 
nor were they powered to make significant conclusions about the efficacy of hypothermia in this popula-
tion. Some did evaluate specific factors that may portend to a better outcome in patients presenting with 
out-of-hospital cardiac arrest due to non-shockable rhythms undergoing hypothermia. Shortcomings 
included incorporating in-hospital cardiac arrest patients in analyses, comparing results of hypothermia 
in shockable versus non-shockable rhythm patients as an outcome measure, lacking standardization in 
cooling protocols, and short-term measures of outcomes. 
Conclusions: It was concluded that further study is needed to characterize patients presenting non-
shockable rhythms who would benefit from hypothermia to better guide its use in this population given 
the costs and implications of treatment and long-term care in those who survive with poor outcomes. 
(Cardiol J 2017; 24, 3: 324–333)
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Introduction
With roughly 400,000 out-of-hospital cardiac 
arrests (OHCA) in the United States per year [1], 
therapeutic hypothermia (TH) or targeted tem-
perature management (TTM) is now the standard 
of care in their management. The pathophysiol-
ogy underlying the effect of body temperature on 
hypoxic-ischemic brain injury has been described 
in detail [2–4]. Improved outcomes have been dem-
onstrated in randomized controlled trials (RCTs) in 
a group of post-anoxic patients who present with 
OHCA due to “shockable rhythms,” ventricular 
fibrillation (VF) or pulseless ventricular tachycar-
dia (VT) [2–4]. 
It has been well established that more pa-
tients are presenting with cardiac arrest (CA) 
due to non-shockable rhythms (nSR), pulseless 
electrical activity (PEA) or asystole, than VT/VF 
[5]. This is possibly related to more aggressive 
cardiac interventions and better long-term medical 
management of coronary disease and heart failure. 
This may ultimately lead to fewer OHCA due to 
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VT/VF [5, 6]. Yet a fewer percentage of patients 
presenting with OHCA due to nSR receive TH/ 
/TTM than those with VT/VF [5]. The largest 
RCTs on TH/TTM in OHCA have excluded nSR 
[2, 3] or were not designed to evaluate the effects 
of hypothermia in nSR as a primary outcome [4]. 
This is likely because studies have revealed sig-
nificantly worse outcomes in OHCA associated 
with nSR, and intervention has been assumed to 
have little benefit given the costs [7, 8]. How-
ever, a hypothermia protocol may be beneficial 
in a subgroup of patients presenting with OHCA 
due to nSR if certain criteria are met [8]. Though 
recent publications support the use of TH/TTM 
in cardiac arrests regardless of rhythm [9, 10], 
understanding the clinical variables that render 
patients suitable candidates for TH/TTM, espe-
cially in those presenting with nSR, is vital given 
that cost-benefit is a reason proposed by some 
institutions to withhold treatment, especially 
when considering the consequences of long-term 
care in survivors with poor outcomes. 
In this article, a review the literature on TH/
TTM in OHCA due to nSR is presented. We point 
out possible clinical features that may make certain 
patients presenting with OHCA due to nSR good 
candidates for intervention and discuss the difficul-
ties in extrapolating the results of these studies to 
refute or support the benefit of TH/TTM in OHCA 
due to nSR. 
Methods
A systematic literature search was performed 
using PUBMED, Ovid, MEDLINE, EMBASE, and 
clinicaltrials.gov  websites first in March, 2015 and 
then again in October, 2016. The primary author (BF) 
performed the search. Both authors (BF, PK) decided 
which studies would be included or excluded. The 
terms “non shockable,” “hypothermia,” and “cardiac 
arrest” in different combinations were used. Studies 
included those which demonstrated outcomes from 
TH in OHCA due to nSR. Studies were excluded if 
it was clearly stated that they included only those 
with shockable rhythms, in-hospital cardiac arrests 
(IHCA) or pediatric patients. Many of the results were 
abstracts submitted to meetings and if results were 
unclear with respect to the efficacy of TH/TTM in 
nSR they were also excluded (Fig. 1).
Each study was evaluated by the quality of 
its data using a categorical system adapted from 
a previously published guideline by American Acad-
emy of Neurology (AAN) [10] which was modified 
by Dr. David Gloss. The quality of each study was 
based on a categorical rating as follows: Category 
I — broad spectrum prospective trial; Category 
II — narrow spectrum, prospective trial or broad 
spectrum retrospective trial; Category III — nar-
row spectrum, retrospective trial or case control 
study; Category IV — review, case series, expert 
opinion paper (Table 1).
Figure 1. Literature search for studies evaluating therapeutic hypothermia (TH)/targeted temperature management 
(TTM) in out-of-hospital cardiac arrests (OHCA) due to non-shockable rhythm (nSR); IHCA — in-hospital cardiac ar-
rests; RCT — randomized controlled trial.
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Table 1. Studies evaluating therapeutic hypothermia (TH)/targeted temperature management (TTM)  
in out-of-hospital cardiac arrests due to non-shockable rhythm.
Study Study type Survival/outcome with TH/TTM Data quality
Studies demonstrating benefit from TH/TTM
Choi [11] Retrospective 
multicenter  
study
OR for survival to discharge: PEA = 2.28 (95% CI 1.69–3.07), 
Asystole = 1.84 (95% CI 1.58–2.15); ORs for good  
outcome (CPC 1–2): PEA = 2.3 (95% CI 1.50–3.53),  
Asystole = 1.07 (CI 0.83–1.38)
Category II data
Lindner [12] Prospective  
multicenter study
17% survived to discharge (p = 0.051); 14% TH vs. 9%  
of controls (p = 0.094) had good outcome
Category III data
Sung [13] Retrospective 
multicenter study
For all nSR — OR for good outcome  
(CPC 1–2) = 2.9 (95% CI 1.9–4.4)
Category III data
Testori [14] Retrospective 
single center 
analysis
Improved survival at 6 months with TH with adjusted  
OR 0.56 (95% CI 0.34–0.93), p = 0.025; 35% of TH-treated 
patients had good outcomes (CPC 1–2) adjusted OR 1.84 
(95% CI 1.08–3.13), p = 0.024
Category III data
Lundbye [15] Retrospective 
single center 
analysis
Adjusted OR for survival to discharge was 5.65 (95% CI 
1.66–19.23), p = 0.06 in TH group; adjusted OR for good 
neurologic outcome from TH was 4.35  
(95% CI 1.10–17.24), p = 0.04
Category III data
Soga [16] Retrospective 
multicenter  
study
59% of patients survived to 30 days with TH; 32% of those 
undergoing TH had a favorable outcome; if ROSC  
< 16 min, outcomes were similar to VT/VF (p = 0.84)
Category III data
Kim (17) Meta-analysis and 
systematic review 
including 2 RCTs,  
6 prospective  
(2 multicenter) 
and 6 retrospec-
tive analyses  
(4 included IHCA 
and OHCA)
Decreased in-hospital mortality (OR 0.84, 95% CI  
0.78–0.92) in the non-randomized studies in  
TH groups; pooled RR for 6 month mortality 0.85  
(95% CI 0.65–1.11) in the 2 RCTs in those  
undergoing TH; trend towards less poor outcomes  
in those undergoing TH (OR 0.95, 95% CI 0.90–1.01)  
in the non-randomized studies
Category IV data
Kim [19] Retrospective 
multicenter  
study
Unadjusted OR 2.34 (95% CI 1.08–5.05) for women and  
unadjusted OR 1.67 (95% CI 1.01–2.75) for men with  
good outcome (CPC 1–2) (under 45 years old);  
Unadjusted OR 1.53 (95% CI 1.09–2.14) for men  
with CPC 1–2 (45–65 years old)
Category II data
Yoshida [39] Retrospective 
single center 
analysis
Significantly more patients with CPC 1–2 (p < 0.0001  
at 3 months) and better survival (p < 0.0001 at 3 months)  
if pulmonary embolism was cause of OHCA; incidental  
hypothermia increased likelihood of 3-month survival  
(p < 0.0001) and good outcome (p < 0.0001) 
Category II data
Fontanals [40] Retrospective 
single center 
analysis
Survival at 12 months — 33.3%  
and CPC 1–2 — 25%
Category III data
Katz [41] Retrospective 
multicenter  
study
No difference in outcomes or survival in patients who  
overdosed vs. non-overdose patients undergoing  
TTM despite more nSR in the overdose group
Category III data
Lee [42] Retrospective 
multicenter  
study
Adjusted OR 2.05 (95% CI 1.51–2.79) for survival to  
discharge in nSR undergoing TH vs. control and OR 1.13 
(95% CI 0.59–2.20) for good neurologic outcome  
in nSR undergoing TH vs. control 
Category II data
Nair [43] Prospective  
single center  
study
Of the 64 post-cardiac arrest patients in the hypothermia 
group, 16 (25%) had a CPC 1–2 (good outcome) which  
was associated with time down and time to CPR 
Category II data
Perman [47] Retrospective 
multicenter  
study
OR 3.1 (95% CI 1.6–5.8) for survival to discharge in those 
undergoing TH in the nSR group; OR 2.1 (95% CI 1.0–4.4) 
for good outcomes in TH in nSR group
Category III data
Æ
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Study Study type Survival/outcome with TH/TTM Data quality
Studies demonstrating no benefit from TH/TTM
Vaahersalo [5] Prospective  
multicenter study
80.6% of those with nSR undergoing TH survived  
with CPC 3–5 (p = 0.56)
Category II data
Martinell [6] Prospective  
single center 
study
OR 0.67 (95% CI 0.31–1.46) for survival at 30 days in group 
undergoing TH and OR 0.64 (95% CI 0.27–1.54) for survival 
at 1 year in this group despite significant increase in use  
of TH; CPC score among survivors was not significantly 
different if undergoing TH (p = 0.36)
Category II data
Frydland [18] Multicenter RCT 
(sub-group  
analysis)
Mortality 84% in TTM33 and TTM36; 13% had  
a good outcome in the TTM33 group and  
15% in the TTM36 group
Category II data
Lopez-de-sa 
[20]
Single center RCT No survivors at 6 months (asystole only) Category II data
Dumas [21] Prospective single 
center study
16% overall survival in the TH group with a trend  
toward better outcomes versus controls  
(OR 0.71, 95% CI 0.37–1.36), p = 0.48
Category II data
Storm [22] Prospective single 
center study
27.59% good outcome in TH group (p = 0.175) Category III data
Wee [23] Retrospective 
multicenter  
study
46/80 patients survived in the TH group; 6/80 patients  
had good outcome; no association of rhythm with  
survival (p = 0.737)
Category III data
Hoffmann [24] Retrospective 
single center 
analysis
None of the OHCA and nSR undergoing hypothermia  
had favorable outcome 
Category III data
Uribarri [25] Retrospective 
single center 
analysis
3/44 in nSR group survived with CPC £ 2, adjusted  
OR 13.8 (95% CI = 3.4–56.1), p < 0.001 compared  
to all undergoing TH
Category III data
Kocjanic [26] Retrospective 
single center 
analysis
9% survived with CPC 1–2 with TH  
(“intensified resuscitation”) (p = 0.27)
Category III data
Ganga [27] Retrospective 
single center 
analysis
17/98 with nSR reached CPC 1–2 Category III data
Gebhardt [28] Retrospective 
single center 
analysis
In TH cohort presence of PEA predicted poor outcome  
(OR 0.09, 95% CI 0.02–0.40 for good outcome, defined  
as disposition home/rehab)
Category III data
Schenone [29] Meta-analysis 
and systematic 
review including 
3 RCTs, 8 cohort 
studies evaluating 
shockable and 
non-shockable 
rhythms (1 RCT 
and 6 cohort 
studies included 
nSR)
Did not specifically evaluate effects of TH on nSR  
separately from a group of pooled results of nSR  
and VT/VF, did evaluate levels of temperature in nSR  
and found non-significant benefit of  
lower temperature vs. higher temperature  
in good outcome (CPC 1–2) in nSR
Category IV data
Modisett [30] Retrospective 
single center 
analysis
11/18 patients with VT/VF and 7/30 patients with  
nSR survived (p = 0.01)
Category III data
Whittaker [31] Retrospective 
single center 
analysis
OR for death 5.6 (95% CI 2.0–15.4), p = 0.018  
when compared nSR to VT/VF, only 3 patients  
with nSR survived to discharge
Category III data
Table 1 (cont.). Studies evaluating therapeutic hypothermia(TH)/targeted temperature management 
(TTM) in out-of-hospital cardiac arrests due to non-shockable rhythm.
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Study Study type Survival/outcome with TH/TTM Data quality
Kim [32] Retrospective 
multicenter study
More patients with nSR than VT/VF in the bad outcome 
group (CPC 3–5) and more VT/VF than nSR patients and 
in the good outcome group (CPC 1–2) (p < 0.01) — likely 
skewed by asystole; multivariate analysis for decreased 
chance of good outcome in nSR with OR 7.13  
(95% CI 4.85–10.48)
Category II data
Afzal [33] Retrospective  
single center 
study
Of those receiving TH: in the VT/VF group — 69% expired, 
23% went home, and 7.7% were sent to nursing facility;  
in the nSR group — 89.7% expired, 7.6% went home  
and 2.5% went to nursing facility
Category III data
Thomsen [34] Retrospective  
single center 
study
nSR was a significant predictor of mortality HR = 2.26 
(95% CI 1.67–3.07), and having any comorbidity noted in 
this study was an independent predictor of mortality in 
nSR HR = 1.67 (95% CI 1.08–2.59) 
Category III data
Lazerri [35] Retrospective 
multicenter  
study
More nSR observed in non-survivors (p = 0.026) who 
showed a longer collapse — recovery of spontaneous  
circulation time (p = 0.01). Only 3/18 survivors  
had presented with nSR, 15/18 had VT/VF
Category III data
Kim [36] Retrospective 
multicenter  
study
Outcomes in nSR associated with time down: 10.3%  
of nSR survived with good outcome (3/29) if downtime  
> 10 min but 61.5% if downtime < 10 min
Category II data
Dell’anna [37] Retrospective 
multicenter  
study
75% of non-survivors had nSR vs. 33% of survivors  
(p > 0.0001); less nSR patients were in the group with  
CPC 1–2 than in the group with CPC 3–5 (p < 0.0001) 
Category III data
Coute [38] Retrospective 
multicenter  
study
10.6% (261 patients) of the total cohort received TH;  
mortality 83.9% in those receiving TH and 78.5% in  
nSR patients in the non-TH group (78.5%) (p = 0.04), 
though differences by rhythm category were observed; 
those that converted to shockable rhythm  
had better outcomes
Category III data
Pfeifer [44] Retrospective 
single center 
analysis
Significantly more patients with CPC 1–2 undergoing  
TH had VT/VF than those with CPC 3–5; no benefit  
in mortality from TH in nSR (p = 0.149) 
Category III data
Idriss-Hachimi 
[45]
Single center  
RCT
15 died in control group, 12 died in TH group  
(no statistical analysis); 2/16 in the TH group had  
CPC 1–2, 0/16 had CPC 1–2 in control
Category II data
Laurent [46] Two center  
RCT
mortality 68% vs. 79% in TH and control;  
CPC 1–2 45% in TH and 26% in control
Category II data
Kim [48] Single center  
RCT
In “non-VF” cohort 9% of field-cooled  
patients survived (p = 0.13)
Category II data
CI — confidence interval; CPC — cerebral performance category; CPR — cardiopulmonary rescucitation; HR — hazard ratio; IHCA — in-hospital 
cardiac arrest; nSR — non-shockable rhythm; OR — odds ratios; OHCA — out-of-hospital cardiac arrests; PEA — pulseless electrical activity; 
RCT — randomized controlled trial; ROSC — return of spontaneous circulation; RR — risk ratio; TH — therapeutic hypothermia; TTM —  
targeted temperature management; VT/VF — ventricular tachycardia/ventricular fibrillation
Table 1 (cont.). Studies evaluating therapeutic hypothermia(TH)/targeted temperature management 
(TTM) in out-of-hospital cardiac arrests due to non-shockable rhythm.
Results
A total of 214 publications were gathered 
from our search, 35 of which were included in this 
analysis [5, 6, 11–43]. In 1 study [18],  a literature 
search was performed which found 12 studies, of 
which 1 retrospective study [44] was not found in 
our search or in any of the meta-analyses. This 
study was added to our analysis. One of the studies 
above was a high quality review and meta-analysis 
of nSR and TH [17] which included 2 RCTs [45] and 
[46] that was analyzed separately, also a non-RCT 
[22] was found in the search. Another more recent 
meta-analysis [29] included 11 trials of patients un-
dergoing TH versus a control group which included 
both shockable and non-shockable rhythms. Most 
of the trials in their analysis had already been found 
in this search or were included in the previous 
meta-analysis that had been reviewed above [17]. 
Three other studies noted in this meta-analysis 
pooled results from TH in OHCA due to nSR and 
VT/VF together, so specific outcomes in nSR were 
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not clarified and were thus excluded. After review-
ing reference lists of the resulting papers above, 
2 more studies not listed in prior searches [47] and 
[48] were discovered. 1 randomized, controlled 
trial currently enrolling [49] was also discovered, 
which focuses on hypothermia protocol in OHCA 
due to nSR. In total, 40 studies were included in 
the present analysis. 
The studies are described in Table 1. The 
results of each study are highlighted based on sur-
vival and good outcomes. Some of the studies used 
cerebral performance category (CPC) scale to define 
good outcomes while others used post-discharge 
disposition. There were 14 studies that demon-
strated benefit with TH/TTM [11–17, 19, 47, 39–43] 
while 26 studies showed unclear or no benefit from 
TH/TTM [5, 6, 18, 20–38, 44–46, 48]. Based on 
a categorical system rating the quality of data, none 
of the studies received a Category I rating. 
Outcome variables
Some of the retrospective studies noted vari-
ables that may have negatively impacted outcomes 
in OHCA. These include delayed time to initiat-
ing cardiopulmonary resuscitation (CPR), less 
bystander CPR, poor CPR quality, longer time to 
return of spontaneous circulation (ROSC), non-car-
diac cause for arrest, medical comorbidities, older 
age, female gender, higher Acute Physiology and 
Chronic Health Evaluation (APACHE) II scores, 
lactic acidosis on admission, and post-resuscitation 
circulatory shock [7, 12, 16, 19–21, 25, 28, 35, 36, 
43, 45]. Some studies cited comparisons between 
nSR and VT/VF with respect to the efficacy of TH/ 
/TTM as major findings [7, 16, 18, 20, 24–28, 30–33, 
35, 44]. One trial concluded that if ROSC was < 16 
min, TH benefitted OHCA due to nSR similarly to 
VT/VF (p = 0.84) [16]. The effect of time down dur-
ing arrest also was described in another trial with 
a cutoff noted at 10 min for improved outcomes [32]. 
Other studies also focused on variables affecting 
outcomes in TH/TTM-treated patients presenting 
with OHCA due to nSR [29, 34–36, 39]. 
Study design
Four of the five RCTs in this review were 
small, with cohort sizes ranging from 6 to 16 sub-
jects [20, 45, 46, 48]. In the subgroup analysis of 
the original TTM study [4], a larger cohort was 
studied but the authors noted that their trial was 
underpowered [18]. Another issue was that the 
RCTs were designed with primary endpoints that 
did not specifically address TH/TTM in nSR. One 
study was designed to evaluate both the feasibility 
of a helmet cooling protocol and effects of hypo-
thermia on serum levels of S-100b, an astroglial 
protein that could be a marker, or direct mediator 
of neuronal injury in OHCA [45]. Another RCT 
was a pilot study designed to obtain initial data 
when using different temperature targets for TH 
and assess TH effect on outcomes [20]. In another 
study, the primary endpoint was to assess differ-
ent levels of hypothermia and their efficacy [18]. 
The two other RCTs in this study were created 
to evaluate hemofiltration [46] and rapid in-field 
cooling in OHCA [25]. 
With respect to comparing outcomes between 
PEA arrest and asystole, one trial found that pa-
tients presenting with OHCA due to PEA arrest 
benefitted more from TH than those with asys-
tole [11]. Others also noted possible differences 
between asystolic and PEA arrest in outcomes in 
those undergoing TH/TTM [32, 38]. 
The change in the goal temperature for cool-
ing, from TH to TTM, could confound results and 
analyses of these studies though they were included 
together in the present study. Differences in cool-
ing protocols, other than target temperature, were 
noted in some trials. In 1 study there was a differ-
ence in the method of hypothermia maintenance 
based on the time of enrollment with roughly half 
of patients undergoing more modern techniques. In 
this same study, there were some patients who did 
not complete the 24-h period of hypothermia [25]. 
Variability in the form of maintenance hypothermia 
was also specifically noted in another non-RCT 
and could have affected outcomes [23]. In another 
study, different cooling methods were used in the 
shockable and non-shockable rhythm groups [45]. 
The time to outcomes measured in most of these 
studies was short.  Other studies with longer-term 
follow up demonstrated good outcomes [14, 17, 40].
Though most trials focused on OHCA, some 
studies included IHCA in their analyses [17, 24, 
27, 28, 37, 41]. Others, which only included ab-
stracts presented at national meetings, may also 
have included these patients though some did not 
specifically address this issue in their presentation. 
Discussion
In this focused review, results were outlined 
from randomized and non-randomized studies of 
TH/TTM in patients presenting with OHCA due to 
nSR. As noted in Table 1, there are few high quality 
studies on this topic. Though it is difficult to make 
broad conclusions from their findings, these studies 
do shed light on some factors that may play a role in 
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outcomes and could guide clinical decision-making 
and highlight shortcomings in design that should 
be kept in mind for future trials. 
Outcome variables
The difficulty with measuring outcomes in 
OHCA due to nSR is that they are more likely to 
have many of these features, particularly when 
compared to VT/VF [7, 12, 16, 18, 24, 25, 45, 47]. 
Also, each clinical variable may not alter outcomes 
in a similar fashion in VT/VF and nSR groups [32, 
34]. Considering the fundamental differences be-
tween these groups, it is not surprising that many 
found that OHCA due to nSR have worse outcomes 
when compared to those with SR with TH/TTM. 
To define the utility of TH/TTM in OHCA due to 
nSR, studies should compare treatment and control 
groups within this population.
Some studies specifically focused on factors 
affecting outcomes in those with nSR undergoing 
TH/TTM, as noted above. However, many that did 
this demonstrated baseline differences that would 
favor survival in the control group, which could 
have confounded the results and therefore one 
cannot make significant conclusions from their find-
ings [11, 12, 16, 19, 21, 26, 28, 47]. Nevertheless, 
evaluating outcome measures in those presenting 
in nSR, without comparing them to those with VT/ 
/VF, should be replicated in future studies. 
Study design
The highest quality studies available are RCTs 
but those were ones that evaluated outcomes in 
TH/TTM in OHCA due to nSR and were not specifi-
cally designed to address the efficacy of TH/TTM 
in OHCA in this subgroup. Also, though the RCTs 
may have been powered for their own primary 
end points, they were too small to determine out-
comes in TH in OHCA due to nSR. These factors 
have likely contributed to the lack of quality data 
available. 
Analyzing PEA and asystolic arrests together 
may not be ideal since it has been demonstrated 
that OHCA due to PEA may portend a better out-
come than those due to asystole [7]. This was also 
demonstrated in the few studies that compared 
their outcomes [11, 32, 38]. Separate analyses 
of PEA and asystolic arrests may help elucidate 
those who would benefit from intervention in 
these groups.
There were differences in cooling methods 
and duration of cooling seen across the randomized 
and non-randomized trials which could have led to 
inconsistent time-to-target temperature and actual 
temperature during the testing period. Optimally, 
cooling protocols could be more consistent in fu-
ture analyses, given that this inconsistency could 
confound results.
Differences between nSR and VT/VF with 
respect to outcomes become less apparent as the 
length of time to follow up is longer [46]. This is 
thought to be due to the fact that more time is 
needed for full recovery after an acute illness and 
brain injury [6]. Most of these trials used short-
term outcome measures at the time of discharge or 
a few months afterward but as noted above, those 
with longer-term follow up showed intervention to 
be beneficial [14, 17, 40]. Analyzing survival and 
neurologic function over a longer time period might 
shed light on the utility of TH/TTM in OHCA due 
to nSR as these patients may derive more benefit 
in the long-term.
Evaluating IHCA with OHCA poses chal-
lenges. IHCA patients are more complicated as 
they often have more varied underlying etiologies, 
which can include more non-cardiac causes and 
a higher rate of nSR, and they often have more active 
medical comorbidities which can negatively affect 
outcomes [24]. A recent article has questioned the 
efficacy of TH/TTM in IHCA [50]. Therefore, OHCA 
and IHCA may be evaluated better separately.
Limitations of the study
This literature review was focused and there-
fore it is possible that some studies had eluded this 
search. Also, given that a meta-analysis was not un-
dertaken, there were a lack of high quality studies, 
variable outcome measures, and confounders limit 
the utility of this study. Substantive conclusions are 
also limited by the scope of the studies themselves. 
The RCTs lack power or an appropriate study de-
sign for our purposes. The non-RCTs are limited 
by inherent shortcomings, including selection bias, 
their varying outcome measures, confounders, and 
some by their small subject sizes, as well as oth-
ers that we have outlined above. Also, given that 
abstracts included data which were presented at 
national meetings, we cannot definitively conclude 
much from them nor can we guarantee they did not 
include IHCA or pediatric patients. 
Conclusions
In this review and analysis of the most recent 
data on TH/TTM in OHCA due to nSR, which 
includes RCTs and non-RCTs, it remained in-
conclusive as to whether TH/TTM has a role in 
post-OHCA care in nSR. Most studies are under-
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powered or not primarily designed to make signifi-
cant conclusions about the efficacy of TH/TTM in 
OHCA due to nSR. In particular, many compared 
the efficacy of TH/TTM in nSR to VT/VF, which is 
problematic due to inherent differences between 
the two groups. Features that may portend better 
results within the nSR group itself, which would 
be useful in defining those who could benefit from 
TH/TTM, were analyzed in some studies but were 
not comprehensive. Analyzing PEA and asystole 
separately, excluding IHCA, normalizing cooling 
protocols, and evaluating longer-term outcomes 
could improve future studies. Based on the results 
of this review, the benefit of TH/TTM in OHCA due 
to nSR is still unclear. An RCT devoted to studying 
this population is currently enrolling patients [49] 
and its results could help shed light on the utility 
of TH/TTM in OHCA due to nSR. Given the pos-
sible efficacy of TH/TTM in OHCA due to nSR, 
the 2015 American Heart Association guidelines 
are well founded [51] and advocate the use of TTM/ 
/TH in OHCA due to nSR while proposing that 
continued study in this field would help to better 
define those that could benefit from TH/TTM to 
avoid withholding a possible life-saving interven-
tion while ensuring that expensive resources are 
not misappropriated. 
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